TP53 Null Mutations Identify Lung Cancer Cell Lines with Highest Sensitivity to the Nontaxane Microtubule Inhibitor Eribulin

Trista K. Hinz(University of Colorado Anschutz Medical Campus), Lynn E. Heasley(University of Colorado Health)
Molecular Pharmacology
May 24, 2021
Cited by 15


Related Papers